Fortune Therapeutics Llp - Company Profile

It is a pharma limited liability partnership based in Hyderabaad, Telangana, India, established in 2018.
2018 Hyderabaad, Telangana, India Active
Last Updated:
Access Report
About Fortune Therapeutics Llp

Fortune Therapeutics Llp, a active limited liability partnership, was established on 28 June 2018 in Hyderabaad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAM-8828. Registered under ROC Roc Hyderabad. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Naveen Kumar Goyal (Designated Partner), Murali Narayana Rao Kurapati (Designated Partner). Past directors included Jinendra Kumar Baid, Nirnay Goyal. Its latest date of accounts and solvency statement 31 March 2022. It is based at H No. 6-3-252/1/7/B/Sf-1, Second Floor, Erramanzil, Hyderabaad, Telangana, 500082.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAM-8828

  • Incorporation Date

    28 June 2018

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 7 Year, 8 Months
  • Last Filing with ROC 31 Mar 2022
Company report

Fortune Therapeutics Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Fortune Therapeutics Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Fortune Therapeutics Llp?
Current Designated Partners
Name Designation Appointment Date Status
Naveen Kumar Goyal Designated Partner 28 Jun 2018 Current
Murali Narayana Rao Kurapati Designated Partner 02 Apr 2019 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 05 Sep 2019 Past
Pramod Abcsdd Designated Partner 02 Apr 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Fortune Therapeutics Llp.

Enhance accessibility to Fortune Therapeutics Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Fortune Therapeutics Llp revenue growth over time
Fortune Therapeutics Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Fortune Therapeutics Llp?

Unlock access to Fortune Therapeutics Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Fortune Therapeutics Llp?

Unlock and access historical data on people associated with Fortune Therapeutics Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Fortune Therapeutics Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortune Therapeutics Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Fortune Therapeutics Llp
Recent Activity within the Organization
  • Annual General Meeting

    Fortune Therapeutics Llp last Annual general meeting of members was held on 31 Mar 2022 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Progress on Fortune Therapeutics Llp has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was documented.

  • Director Appointment

    Murali Narayana Rao Kurapati was appointed as a Designated Partner was appointed as a Designated Partner on 02 Apr 2019 & has been associated with this company since 6 years 11 months . was recorded as a recent event.

  • Director Appointment

    Progress on Naveen Kumar Goyal was appointed as a Designated Partner was appointed as a Designated Partner on 28 Jun 2018 & has been associated with this company since 7 years 8 months . was documented.

  • LLP Incorporation

    The activity Fortune Therapeutics Llp was registered on 28 Jun 2018 with Roc Hyderabad & aged 7 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Fortune Therapeutics Llp?

The LLPIN of Fortune Therapeutics Llp is AAM-8828.

Where is Fortune Therapeutics Llp headquartered?

Fortune Therapeutics Llp is headquartered at H No. 6-3-252/1/7/B/Sf-1, Second Floor, Erramanzil, Hyderabaad, Telangana, 500082.

When was Fortune Therapeutics Llp incorporated?

Fortune Therapeutics Llp was incorporated on 28 June 2018.

Who are the current directors of Fortune Therapeutics Llp?

The current directors of Fortune Therapeutics Llp are

What is the primary industry of Fortune Therapeutics Llp?

The primary industry of Fortune Therapeutics Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available